Mechanical Stress, Cytoskeleton, and Autophagy

2026-08-18

PD 173074: From PAAD Drug Signal to Assay Plan

2026-08-18

PD 173074 connects computational drug prioritization in pancreatic adenocarcinoma with experimentally testable FGFR1 and VEGFR2 biology. This guide explains how to translate the Yan et al. study into rigorous kinase, angiogenesis, and cancer research workflows without overstating predictive evidence.

SAN–Cardiac Plexus Assembloids Model Pacemaker Maturation

2026-08-17

The reference study introduces human pluripotent stem cell-derived sinoatrial node–cardiac plexus assembloids that reproduce key structural, molecular, and electrophysiological features of innervation-associated pacemaker maturation. By combining assembloid functional assays with human SAN spatial transcriptomics, the authors identify a CGPO-derived prosaposin–GPR37 signaling program and establish a tractable platform for studying neuro-cardiac control of rhythm.

Ginsenoside Rg1: Neuroimmune Research Workflow

2026-08-17

Build a mechanistic neuroprotection workflow around Ginsenoside Rg1, from solvent preparation and anesthesia challenge to behavioral, inflammatory, synaptic, gut-barrier, and regulatory T-cell readouts. The approach distinguishes broad neuroimmune rescue from single-endpoint apoptosis and inflammation research by testing whether Treg-dependent gut–immune–brain restoration explains the phenotype.

FH1 Small Molecule for iHep Maturation

2026-08-16

FH1 small molecule helps convert iPS-derived hepatocyte-like cells into more functional, mature cultures by improving albumin secretion, morphology, and CYP3A4-associated performance while lowering AFP. This article turns those findings into a practical screening workflow and explains how mature liver models may support carefully controlled gene-regulation assays.

SGC-CBP30: Testing Super-Enhancer Dependency

2026-08-15

SGC-CBP30 is a selective CREBBP/EP300 bromodomain inhibitor for dissecting transcriptional coactivator dependence in epigenetics research. This article translates lung adenocarcinoma findings into a rigorous, tiered assay strategy while clarifying what bromodomain inhibition can—and cannot—prove.

CA-074 Me for Lysosomal Cathepsin B Studies

2026-08-14

CA-074 Me provides a cell-permeable way to test whether cathepsin B activity links lysosomal membrane permeabilization to regulated cell death. This workflow-oriented guide covers dosing, live-cell imaging, apoptosis assay design, selectivity controls, and translation to TNF-α-driven inflammation research.

Biotin-16-UTP: Designing RNA–Protein Assays

2026-08-14

Biotin-16-UTP enables controlled biotin-labeled RNA production for capture, detection, and interaction experiments. This guide connects reagent design to endogenous protein imaging, showing how orthogonal assays can separate RNA binding from native protein localization.

Cisplatin (CDDP): Reading Resistance Mechanisms

2026-08-13

Cisplatin and CDDP remain powerful tools for cancer research, but resistance analysis requires more than a viability endpoint. This article translates recent ferroptosis findings into practical apoptosis assay, chemoresistance, and translational study decisions.

LY364947: TGF-β Type I Kinase Inhibitor

2026-08-13

LY364947 is a selective TGF-β type I receptor kinase inhibitor for preclinical studies of Smad2 phosphorylation, epithelial-mesenchymal transition (EMT), fibrosis, and retinal injury. Product information describes pathway inhibition, EMT-marker changes, and DMSO-based handling requirements, while independent pancreatic cancer research provides contextual evidence for TGF-β/Smad pathway crosstalk rather than direct validation of LY364947.

OTUD3, SLC7A11, and Sunitinib Resistance in ccRCC

2026-08-12

The reference study identifies OTUD3-mediated deubiquitination of SLC7A11 as a mechanism that preserves cystine uptake, limits oxidative stress, and suppresses sunitinib-induced ferroptosis in clear cell renal cell carcinoma. Its findings connect protein stability control with lipid peroxide biology and suggest that OTUD3 may be investigated as a way to restore drug sensitivity, although clinical validation remains necessary.

Flubendazole: Autophagy Research Guide

2026-08-12

Flubendazole is a benzimidazole-derived autophagy activator for controlled laboratory studies of cellular degradation and signaling. Its defined composition, DMSO compatibility, and research-only status support assay planning, while liver-fibrosis findings on glutamine metabolism should not be interpreted as direct evidence for Flubendazole efficacy.

PEI MW 40,000 for Cuproptosis Assays

2026-08-11

Polyethylenimine Linear (PEI), MW 40,000 provides a scalable route for DNA delivery when studying AC008406.3, docetaxel response, and cuproptosis. This article connects PEI transfection chemistry with assay design, controls, and interpretation rather than treating transfection efficiency as the only endpoint.

From Surface Tags to Synaptic Mechanism

2026-08-11

A translational framework for using Sulfo-NHS-SS-Biotin to connect neuronal receptor surface expression with calcium signaling, affinity workflows, and mechanistic decision-making.

ROS-Degradable LNPs for Tumor-Selective mRNA

2026-08-10

The reference study developed a combinatorial library of thioketal-containing, ROS-degradable lipids and identified BAmP-TK-12 as a preferential mRNA carrier for tumor cells. Delivery of DUF5 mRNA enabled mutant RAS depletion and produced stronger antitumor effects than a small-molecule RAS inhibitor in the reported models, while also highlighting important limits in selectivity, biodistribution, and translational validation.